These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease. Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ. Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352 [Abstract] [Full Text] [Related]
13. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467 [Abstract] [Full Text] [Related]
15. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate. Castaman G, Tosetto A, Rodeghiero F. Am J Hematol; 1992 Oct; 41(2):132-6. PubMed ID: 1415174 [Abstract] [Full Text] [Related]